Lack of Early Change in Disease Activity Score Predicts the Likelihood of Achieving Low Disease Activity at Month 6: Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis

被引：0
|
作者：
Keystone, Edward [1 ]
van Vollenhoven, Ronald F. [2 ]
Wilkinson, Bethanie [3 ]
Fallon, Lara [4 ]
Hwang, Lie-Ju [5 ]
Chapman, Douglass [5 ]
DeMasi, Ryan [5 ]
Lee, Eun Bong [6 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON, Canada
[2] Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Pfizer Canada, Montreal, PQ, Canada
[5] Pfizer Inc, New York, NY USA
[6] Seoul Natl Univ, Seoul, South Korea
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1608
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study
    Kubo, Satoshi
    Yamaoka, Kunihiro
    Amano, Koichi
    Nagano, Shuji
    Tohma, Shigeto
    Suematsu, Eiichi
    Nagasawa, Hayato
    Iwata, Kanako
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2017, 56 (08) : 1293 - 1301
  • [32] Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate
    Nielsen, Ulla Bregendahl
    Bruhn, Laerke Valsoe
    Ellingsen, Torkell
    Stengaard-Pedersen, Kristian
    Hornung, Nete
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (1-2) : 62 - 67
  • [33] The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease
    Matucci-Cerinic, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (01) : 34 - 35
  • [34] Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate
    Kooloos, Wouter M.
    Guchelaar, Henk-Jan
    Huizinga, Tom W. J.
    Wessels, Judith A. M.
    RHEUMATOLOGY, 2009, 48 (09) : 1176 - 1177
  • [35] Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis
    de Rotte, Maurits C. F. J.
    den Boer, Ethan
    de Jong, Pascal H. P.
    Pluijm, Saskia M. F.
    Calasan, Maja Bulatovic
    Weel, Angelique E.
    Huisman, A. Margriet
    Gerards, Andreas H.
    van Schaeybroeck, Barbara
    Wulffraat, Nico M.
    Lindemans, Jan
    Hazes, Johanna M. W.
    de Jonge, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 408 - 414
  • [36] Effect of Oral to Subcutaneous Switch of Methotrexate on Disease Activity in Rheumatoid Arthritis Patients
    Aktekin, Lale Akbulut
    Eser, Filiz
    Bodur, Hatice
    Tutoglu, Ahmet
    TURKISH JOURNAL OF RHEUMATOLOGY-TURK ROMATOLOJI DERGISI, 2009, 24 (03): : 140 - 143
  • [37] In Early Rheumatoid Arthritis Patients with Non-Response to Methotrexate Monotherapy the Change in Multi-Biomarker Disease Activity Score Is Differentially Associated with Subsequent Response to Non-Biological Versus Biological Therapy
    Hambardzumyan, Karen
    Bolce, R. J.
    Saevarsdottir, Saedis
    Forslind, Kristina
    Petersson, Ingemar F.
    Geborek, Pierre
    Sasso, Eric H.
    Chernoff, David
    Cruickshank, Scott
    van Vollenhoven, Ronald F.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S155 - S155
  • [38] Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial
    Burmester, Gerd R.
    Rigby, William F.
    van Vollenhoven, Ronald F.
    Kay, Jonathan
    Rubbert-Roth, Andrea
    Blanco, Ricardo
    Kadva, Alysha
    Dimonaco, Sophie
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1279 - 1284
  • [39] Switch from Tocilizumab plus Methotrexate to Tocilizumab Monotherapy. Maintenance of Response in Patients with Rheumatoid Arthritis at Low Disease Activity.
    Pablos, Jose L.
    Navarro Sarabia, F.
    Blanco, Francisco J.
    Roman Ivorra, Jose Andres
    Alonso, Alberto
    Martin-Mola, Emilio
    Cantalejo-Moreira, Miguel
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [40] Tocilizumab Combination Therapy or Monotherapy or Methotrexate Monotherapy in Methotrexate-Naive Patients with Early Rheumatoid Arthritis: 2-Year Clinical and Radiographic Results from a Randomized, Placebo-Controlled Trial.
    Burmester, Gerd
    Rigby, William
    van Vollenhoven, Ronald F.
    Kay, Jonathan
    Rubbert-Roth, Andrea
    Blanco, Ricardo
    Kelman, Ariella
    Dimonaco, Sophie
    Mitchell, Nina
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S811 - S812
12345